Nabriva Therapeutics plc (NBRVF)

Nabriva Therapeutics Revenue

Nabriva Therapeutics had revenue of $2.24M in the quarter ending June 30, 2023, a decrease of -75.60%. This brings the company's total for the last twelve months to $29.56M, down -16.35% year-over-year. In the year 2022, Nabriva Therapeutics had annual revenue of $36.94M with 27.82% growth. That makes Nabriva Therapeutics the 31,431st largest company in the world by revenue and 4,154th in the United States.

• Revenue (ttm): 29.56M
• Revenue Growth: -16.35%
• P/S Ratio: 0.00
• Revenue / Employee: 757.87K
• Employees: 39
• Market Cap: 323.00

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	36.94M	8.04M	27.82%
Dec 31, 2021	28.90M	23.87M	474.80%
Dec 31, 2020	5.03M	-4.45M	-46.98%
Dec 31, 2019	9.48M	-175.00K	-1.81%
Dec 31, 2018	9.66M	4.34M	81.54%

Data Source: S&P Global Market Intelligence Last updated: Oct 19, 2023

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error